Christopher Moertel, MD

Dr. Moertel graduated from the University of Minnesota Medical School. He completed his internship and residency in Pediatrics at the Baylor College of Medicine in Houston, Texas. He then completed his fellowship in Pediatric Hematology and Oncology at the Mayo Clinic/ Mayo Graduate School of Medicine in Rochester, Minnesota. He joined the medical staff at Children’s Hospitals and Clinics of Minnesota in 1990. He is currently the Medical director of the Journey Clinic. While at Children’s, he served as Chief of Staff, Medical Director of Hematology/Oncology, and Lead Physician in the Theodora Lang Oncology Clinic, among other leadership positions. While at Children’s, he was co-director of neuro-oncology, founder and medical director of the Neurocutaneous Syndromes Clinic Without Walls, and attending physician in the Fairview/University Hemophilia and Thrombosis Center. Dr. Moertel has served on numerous national and local professional committees and is the author of a number of book chapters, articles, and abstracts. Special interests include rare pediatric tumors, neurofibromatosis-associated neoplasia, and the therapy of children with brain and spinal cord tumors.

• Team Science Award, Department of Pediatrics, University of Minnesota (2020)
• Minnesota Monthly “Top Doctors” (2016-2019, 2021, 2022)
• Minneapolis - St. Paul “Top Doctors” (2006-2008, 2010-2017, 2020-2022)
• Best Doctors in America® (2007-2013)
• Outstanding Care Provider, Hemophilia Foundation of Minnesota and the Dakotas (2000)
• Physician Teaching Award, Children’s Hospitals and Clinics (2000)
• Outstanding Faculty Educator Award, Department of Pediatrics, University of Minnesota (1999)
• Distinguished Teacher in Pediatrics, University of Minnesota (1992-1993)

• Keng VW, Rahrmann EP, Watson AL, Tschida BR, Moertel CL, Jessen WJ, Rizvi TA, Collins MH, Ratner N, Largaespada DA. PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors. Cancer Res. 2012 Jul 1;72(13):3405-13. Epub 2012 Jun 14. PMID: 22700876 [PubMed - in process]
• Priest JR, Hill DA, Williams GM, Moertel CL, Messinger Y, Finkelstein MJ, Dehner LP; International Pleuropulmonary Blastoma Registry. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol. 2006 Sep 20;24(27):4492-8. PMID: 16983119 [PubMed - indexed for MEDLINE]
• Perko R, Messinger Y, Moertel C. Pseudometastasis secondary to histoplasmosis infection: false-positive PET/CT findings. Pediatr Blood Cancer. 2010 Apr;54(4):621-3. PMID: 19998468 [PubMed - indexed for MEDLINE]
• Yi JS, Moertel CL, Baker KS. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr. 2009 May;154(5):766-8. PMID: 19364562 [PubMed - indexed for MEDLINE]